FDA issues guidance on enterovirus nucleic acid assays
Device Regulation Alert: Safety, Compliance and Reimbursement News, January 12, 2009
Any firm that submits a 510(k) for enterovirus nucleic acid assays must show that its device addresses safety and effectiveness concerns identified in new FDA guidance.
An enterovirus nucleic acid assay is intended to amplify and detect enterovirus RNA in human cerebrospinal fluid. The new guidance is designated as a special control. This special control guidance recommends specific information for mitigating risks and covers classification regulations and product codes for enterovirus nucleic acid assays.
Comments
0 comments on “FDA issues guidance on enterovirus nucleic acid assays ”
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- Q/A: Coding for telescopic intraocular lens
- New FAQ posted on storing laryngoscope blades
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- "Wall fountains" may be spreading Legionnaires to patients, visitors
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Searched
